Cysteine protease inhibitors are a class of compounds that specifically inhibit the activity of cysteine proteases, enzymes that play crucial roles in various biological processes, including protein degradation, cell signaling, and apoptosis. The substance with the CAS number 921625-62-9 is a specific cysteine protease inhibitor that is often studied for its potential therapeutic applications, particularly in the context of diseases where cysteine proteases are implicated, such as cancer and infectious diseases. These inhibitors typically possess a reactive functional group that interacts with the active site of the protease, thereby blocking its enzymatic activity. Characteristics of cysteine protease inhibitors may include their molecular structure, which often features a core scaffold that allows for binding to the protease, as well as their solubility, stability, and selectivity for specific protease targets. Additionally, they may exhibit varying degrees of potency and efficacy, making them valuable tools in both research and clinical settings for modulating protease activity.

Cysteine Protease inhibitor

921625-62-9: Cysteine protease inhibitors are a class of compounds that specifically inhibit the activity of cysteine proteases, enzymes that play crucial roles in various biological processes, including protein degradation, cell signaling, and apoptosis. The substance with the CAS number 921625-62-9 is a specific cysteine protease inhibitor that is often studied for its potential therapeutic applications, particularly in the context of diseases where cysteine proteases are implicated, such as cancer and infectious diseases. These inhibitors typically possess a reactive functional group that interacts with the active site of the protease, thereby blocking its enzymatic activity. Characteristics of cysteine protease inhibitors may include their molecular structure, which often features a core scaffold that allows for binding to the protease, as well as their solubility, stability, and selectivity for specific protease targets. Additionally, they may exhibit varying degrees of potency and efficacy, making them valuable tools in both research and clinical settings for modulating protease activity.

4-((4′-(AMINOMETHYL)-[1,1′-BIPHENYL]-3-YL)OXY)PYRIMIDINE-2-CARBONITRILE

Cysteine protease inhibitors are inhibitors of cysteine proteases. Target: Cysteine Protease

CAS 921625-62-9

Cysteine Protease inhibitor

Cysteine Protease inhibitor

Ref: IN-DA00GU2S

4-((4′-(AMINOMETHYL)-[1,1′-BIPHENYL]-3-YL)OXY)PYRIMIDINE-2-CARBONITRILE

Ref: 10-F800556

Cysteine Protease inhibitor

Ref: TM-T10925